Literature DB >> 24277457

Common and complex Notch1 mutations in Chinese oral squamous cell carcinoma.

Xiaomeng Song1, Ronghui Xia, Jiang Li, Zhifeng Long, Hening Ren, Wantao Chen, Li Mao.   

Abstract

PURPOSE: To determine Notch1 mutation status in oral squamous cell carcinoma (OSCC) from Chinese population and its potential clinical implications. EXPERIMENTAL
DESIGN: Surgically resected OSCC tissues from 51 Chinese patients and 13 head and neck squamous cell carcinoma (HNSCC) cell lines were sequenced for mutations in the entire coding regions of Notch1 and TP53 using a next-generation sequencing platform. Sequences of the genes were also determined in corresponding normal tissues from 46 of the 51 patients. Mutations and their association with clinical parameters were analyzed.
RESULTS: Six mutations in Notch1 and 11 mutations in TP53 coding regions were detected in 4 (31%) and 10 (77%) of the 13 HNSCC cell lines, respectively. Forty-two somatic Notch1 mutations, including 7 nonsense mutations and 11 mutations within the domain commonly harboring potential activating mutations in acute lymphoblastic leukemia, were detected in 22 (43%) of the 51 Chinese OSCC tumors. In comparison, 25 somatic TP53 mutations were observed in 21 (41%) of the 51 tumors. Patients whose tumors carried Notch1 mutation had significantly shorter overall and disease-free survivals (P = 0.004 and P = 0.001, respectively, by log-rank test) compared with those whose tumors carried no Notch1 mutation. Multivariate analysis showed that both Notch1 mutation and lymph node metastasis are independent prognostic factors in the patient population (P = 0.001). All 15 patients with both Notch1 mutation and nodal metastasis recurred or metastasized within 2 years after surgery.
CONCLUSIONS: Notch1 mutation is common in Chinese OSCC and associates with clinical outcomes. The complexity of the mutation spectrum warrants further investigation of Notch1 in Chinese patients with OSCC. ©2013 AACR.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24277457      PMCID: PMC3946562          DOI: 10.1158/1078-0432.CCR-13-1050

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  32 in total

1.  Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.

Authors:  Andrew P Weng; Adolfo A Ferrando; Woojoong Lee; John P Morris; Lewis B Silverman; Cheryll Sanchez-Irizarry; Stephen C Blacklow; A Thomas Look; Jon C Aster
Journal:  Science       Date:  2004-10-08       Impact factor: 47.728

2.  An integrated semiconductor device enabling non-optical genome sequencing.

Authors:  Jonathan M Rothberg; Wolfgang Hinz; Todd M Rearick; Jonathan Schultz; William Mileski; Mel Davey; John H Leamon; Kim Johnson; Mark J Milgrew; Matthew Edwards; Jeremy Hoon; Jan F Simons; David Marran; Jason W Myers; John F Davidson; Annika Branting; John R Nobile; Bernard P Puc; David Light; Travis A Clark; Martin Huber; Jeffrey T Branciforte; Isaac B Stoner; Simon E Cawley; Michael Lyons; Yutao Fu; Nils Homer; Marina Sedova; Xin Miao; Brian Reed; Jeffrey Sabina; Erika Feierstein; Michelle Schorn; Mohammad Alanjary; Eileen Dimalanta; Devin Dressman; Rachel Kasinskas; Tanya Sokolsky; Jacqueline A Fidanza; Eugeni Namsaraev; Kevin J McKernan; Alan Williams; G Thomas Roth; James Bustillo
Journal:  Nature       Date:  2011-07-20       Impact factor: 49.962

3.  Up-regulation of enhancer of zeste homolog 2 is associated positively with cyclin D1 overexpression and poor clinical outcome in head and neck squamous cell carcinoma.

Authors:  Wei Cao; Zhien Feng; Zhibin Cui; Chenping Zhang; Zhaoyao Sun; Li Mao; Wantao Chen
Journal:  Cancer       Date:  2011-10-11       Impact factor: 6.860

4.  Relationship between p53 mutation incidence in oral cavity squamous cell carcinomas and patient tobacco use.

Authors:  P Lazarus; J Stern; N Zwiebel; A Fair; J P Richie; S Schantz
Journal:  Carcinogenesis       Date:  1996-04       Impact factor: 4.944

5.  Notch pathway activation induces neuroblastoma tumor cell growth arrest.

Authors:  Peter E Zage; Riitta Nolo; Wendy Fang; John Stewart; Guillermo Garcia-Manero; Patrick A Zweidler-McKay
Journal:  Pediatr Blood Cancer       Date:  2011-07-08       Impact factor: 3.167

6.  Metastatic colon cancer cells negotiate the intravasation Notch.

Authors:  Gerhard Christofori
Journal:  Cancer Cell       Date:  2011-01-18       Impact factor: 31.743

7.  Alterations of the Notch pathway in lung cancer.

Authors:  Britta Westhoff; Ivan N Colaluca; Giovanni D'Ario; Maddalena Donzelli; Daniela Tosoni; Sara Volorio; Giuseppe Pelosi; Lorenzo Spaggiari; Giovanni Mazzarol; Giuseppe Viale; Salvatore Pece; Pier Paolo Di Fiore
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-10       Impact factor: 11.205

8.  Tyrosine phosphorylation as a marker for aberrantly regulated growth-promoting pathways in cell lines derived from head and neck malignancies.

Authors:  M Cardinali; H Pietraszkiewicz; J F Ensley; K C Robbins
Journal:  Int J Cancer       Date:  1995-03-29       Impact factor: 7.396

9.  gamma-Secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity.

Authors:  Raymond D Meng; Christopher C Shelton; Yue-Ming Li; Li-Xuan Qin; Daniel Notterman; Philip B Paty; Gary K Schwartz
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

10.  Epidermal Notch1 loss promotes skin tumorigenesis by impacting the stromal microenvironment.

Authors:  Shadmehr Demehri; Ahu Turkoz; Raphael Kopan
Journal:  Cancer Cell       Date:  2009-07-07       Impact factor: 31.743

View more
  35 in total

Review 1.  Molecular biology and immunology of head and neck cancer.

Authors:  Theresa Guo; Joseph A Califano
Journal:  Surg Oncol Clin N Am       Date:  2015-04-20       Impact factor: 3.495

Review 2.  Notch Signaling and Human Papillomavirus-Associated Oral Tumorigenesis.

Authors:  Trinath Das; Rong Zhong; Michael T Spiotto
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Notch1 mutations are drivers of oral tumorigenesis.

Authors:  Evgeny Izumchenko; Kai Sun; Sian Jones; Mariana Brait; Nishant Agrawal; Wayne Koch; Christine L McCord; David R Riley; Samuel V Angiuoli; Victor E Velculescu; Wei-Wen Jiang; David Sidransky
Journal:  Cancer Prev Res (Phila)       Date:  2014-11-18

Review 4.  Emerging biomarkers in head and neck cancer in the era of genomics.

Authors:  Hyunseok Kang; Ana Kiess; Christine H Chung
Journal:  Nat Rev Clin Oncol       Date:  2014-11-18       Impact factor: 66.675

5.  Combined Erlotinib and PF-03084014 treatment contributes to synthetic lethality in head and neck squamous cell carcinoma.

Authors:  Yang Zheng; Zhao Wang; Xu Ding; Yibo Dong; Wei Zhang; Wei Zhang; Yi Zhong; Wenyi Gu; Yunong Wu; Xiaomeng Song
Journal:  Cell Prolif       Date:  2017-12-12       Impact factor: 6.831

6.  Molecular biology of oral cavity squamous cell carcinoma.

Authors:  Phillip J Hsu; Kenneth Yan; Hailing Shi; Evgeny Izumchenko; Nishant Agrawal
Journal:  Oral Oncol       Date:  2020-01-07       Impact factor: 5.337

Review 7.  Sequencing the head and neck cancer genome: implications for therapy.

Authors:  Wenyue Sun; Joseph A Califano
Journal:  Ann N Y Acad Sci       Date:  2014-12-01       Impact factor: 5.691

Review 8.  Molecular mechanisms of ethanol-associated oro-esophageal squamous cell carcinoma.

Authors:  Yao Liu; Hao Chen; Zheng Sun; Xiaoxin Chen
Journal:  Cancer Lett       Date:  2015-03-09       Impact factor: 8.679

9.  Notch1 regulates tongue cancer cells proliferation, apoptosis and invasion.

Authors:  Rui-Huan Gan; Hua Wei; Jing Xie; Dan-Ping Zheng; Er-Ling Luo; Xiao-Yu Huang; Jian Xie; Yong Zhao; Lin-Can Ding; Bo-Hua Su; Li-Song Lin; Da-Li Zheng; You-Guang Lu
Journal:  Cell Cycle       Date:  2017-12-21       Impact factor: 4.534

Review 10.  The NOTCH Pathway in Head and Neck Squamous Cell Carcinoma.

Authors:  T Fukusumi; J A Califano
Journal:  J Dent Res       Date:  2018-02-28       Impact factor: 6.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.